Healthpeak prices $500 million in senior unsecured notes due 2033

Published 05/08/2025, 22:38
Healthpeak prices $500 million in senior unsecured notes due 2033

DENVER - Healthpeak Properties, Inc. (NYSE:DOC), a $12.19 billion market cap healthcare REIT, announced Tuesday that its operating company has priced a $500 million public offering of 4.750% senior unsecured notes due 2033. The notes were priced at 99.178% of the principal amount.

The healthcare real estate investment trust, which boasts a strong current ratio of 4.01 and has maintained dividend payments for 41 consecutive years according to InvestingPro, expects to generate approximately $492.8 million in net proceeds from the offering after deducting underwriting discounts but before other fees and expenses.

According to the company’s statement, proceeds will be used to repay borrowings under its commercial paper program and for general corporate purposes, which may include debt repayment, working capital, acquisitions, development activities, and capital expenditures. The company has demonstrated solid growth with revenue increasing 15.91% over the last twelve months.

The notes will be senior unsecured obligations of Healthpeak OP, LLC and fully guaranteed by Healthpeak Properties, DOC DR Holdco, LLC, and DOC DR, LLC.

PNC Capital Markets LLC, J.P. Morgan Securities LLC, Credit Agricole Securities (USA) Inc., Truist Securities, Inc., and U.S. Bancorp Investments, Inc. are serving as joint book-running managers for the offering.

The transaction is expected to close on August 14, 2025, subject to customary closing conditions.

Healthpeak Properties is a fully integrated real estate investment trust that owns, operates, and develops real estate focused on healthcare discovery and delivery. The company is a member of the S&P 500 index.

The information in this article is based on a press release statement issued by the company.

In other recent news, Healthpeak Properties reported its second-quarter 2025 earnings, revealing mixed results. The company’s earnings per share (EPS) fell short of expectations at $0.05, compared to the forecasted $0.064, a miss of 21.88%. However, Healthpeak’s revenue slightly surpassed projections, totaling $694.35 million against the anticipated $689.32 million. Scotiabank downgraded Healthpeak Properties from Sector Outperform to Sector Perform, citing weak leasing performance and growing laboratory credit risk concerns. Meanwhile, KeyBanc maintained its Sector Weight rating on the company, highlighting ongoing lab occupancy issues affecting the healthcare REIT’s performance. Healthpeak also updated its "United States Federal Income Tax Considerations" section in its prospectus, as filed with the Securities and Exchange Commission. These developments reflect the company’s current challenges and adjustments in the healthcare real estate sector.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.